Medical Net, Inc.

  • Market Cap: Micro Cap
  • Industry: Media & Entertainment
  • ISIN: JP3752400006
JPY
231.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Feb'26
Nov'25
Aug'25
May'25
Feb'25
Nov'24
Aug'24
Net Sales
1,620.18
1,769.49
1,561.00
1,655.15
1,508.64
1,551.42
1,358.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,620.18
1,769.49
1,561.00
1,655.15
1,508.64
1,551.42
1,358.39
Raw Material Cost
1,141.78
1,269.28
1,054.42
1,155.95
1,034.05
1,021.22
900.61
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.11
3.60
3.27
2.61
3.02
3.40
2.53
Selling and Distribution Expenses
451.30
430.06
482.43
459.78
450.32
477.16
454.22
Other Expenses
-0.41
-0.36
-0.33
-0.17
0.87
0.08
0.45
Total Expenditure (Excl Depreciation)
1,593.08
1,699.34
1,536.85
1,616.62
1,496.13
1,502.61
1,361.83
Operating Profit (PBDIT) excl Other Income
27.1
70.1
24.2
38.5
12.5
48.8
-3.4000000000000004
Other Income
37.94
46.35
26.30
361.06
13.98
25.18
2.46
Operating Profit (PBDIT)
84.81
135.86
69.55
418.61
47.57
92.22
17.29
Interest
4.11
3.60
3.27
2.61
3.02
3.40
2.53
Exceptional Items
0.00
-0.44
4.80
-322.55
-131.53
-4.39
-3.87
Gross Profit (PBDT)
478.41
500.21
506.58
499.20
474.60
530.21
457.77
Depreciation
19.77
19.36
19.10
19.02
21.09
18.22
18.27
Profit Before Tax
60.95
112.45
51.98
74.43
-108.07
66.22
-7.39
Tax
21.87
36.53
18.16
-4.68
10.08
35.29
22.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.63
68.94
21.60
77.14
-128.25
18.45
-35.49
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.63
68.94
21.60
77.14
-128.25
18.45
-35.49
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.45
6.98
12.22
1.97
10.10
12.47
5.98
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
39.08
75.92
33.82
79.12
-118.15
30.93
-29.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,985.52
1,948.59
1,869.82
1,715.81
1,657.49
1,848.94
1,842.66
Earnings per share (EPS)
3.74
7.46
2.4
8.83
-14.28
2.05
-3.92
Diluted Earnings per share
3.74
7.46
2.4
8.83
-14.28
2.05
-3.92
Operating Profit Margin (Excl OI)
1.67%
3.96%
1.55%
2.33%
0.83%
3.15%
-0.25%
Gross Profit Margin
4.98%
7.45%
4.55%
5.65%
-5.77%
5.44%
0.8%
PAT Margin
2.14%
3.9%
1.38%
4.66%
-8.5%
1.19%
-2.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Feb 2026 is -8.44% vs 13.36% in Nov 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Feb 2026 is -48.48% vs 124.56% in Nov 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Feb 2026 is -47.60% vs 106.70% in Nov 2025

stock-summary

Interest

QoQ Growth in quarter ended Feb 2026 is 13.89% vs 9.09% in Nov 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Feb 2026 has fallen from Nov 2025

Compare Quarterly Results Of Medical Net, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
1,620.18
4,129.69
-2,509.51
-60.77%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,620.18
4,129.69
-2,509.51
-60.77%
Raw Material Cost
1,141.78
2,694.33
-1,552.55
-57.62%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.11
0.49
3.62
738.78%
Selling and Distribution Expenses
451.30
1,368.47
-917.17
-67.02%
Other Expenses
-0.41
-0.05
-0.36
-720.00%
Total Expenditure (Excl Depreciation)
1,593.08
4,062.80
-2,469.72
-60.79%
Operating Profit (PBDIT) excl Other Income
27.11
66.89
-39.78
-59.47%
Other Income
37.94
36.63
1.31
3.58%
Operating Profit (PBDIT)
84.81
103.52
-18.71
-18.07%
Interest
4.11
0.49
3.62
738.78%
Exceptional Items
0.00
-182.58
182.58
100.00%
Gross Profit (PBDT)
478.41
1,435.36
-956.95
-66.67%
Depreciation
19.77
0.00
19.77
Profit Before Tax
60.95
-79.55
140.50
176.62%
Tax
21.87
0.02
21.85
109,250.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
34.63
-78.64
113.27
144.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
34.63
-78.64
113.27
144.04%
Share in Profit of Associates
0
0
0.00
Minority Interest
4.45
-0.93
5.38
578.49%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
39.08
-79.57
118.65
149.11%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,985.52
2,904.06
-918.54
-31.63%
Earnings per share (EPS)
3.74
-2.06
5.80
281.55%
Diluted Earnings per share
3.74
-2.06
5.80
281.55%
Operating Profit Margin (Excl OI)
1.67%
1.62%
0.00
0.05%
Gross Profit Margin
4.98%
-1.93%
0.00
6.91%
PAT Margin
2.14%
-1.90%
0.00
4.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 162.02 Million
in Feb 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2026 is -8.44% vs 13.36% in Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 is 7.40% vs 14.84% in Feb 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.91 Million
in Feb 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2026 is -48.48% vs 124.56% in Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 is 133.08% vs -82.41% in Feb 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.69 Million
in Feb 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2026 is -47.60% vs 106.70% in Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 is 39.58% vs -56.14% in Feb 2025

Quarterly - Interest
Interest 0.41 Million
in Feb 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2026 is 13.89% vs 9.09% in Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 is 36.67% vs 76.47% in Feb 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.67%
in Feb 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Feb 2026 has fallen from Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 has improved from Feb 2025